oral semaglutide weight loss effectiveness 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial Semaglutide Injections Kirkland & Bellevue

Type 2 diabetes mellitus (T2DM) is a major risk factor for cardiovascular disease

A UVA Health cardiologist sees more upside than down to new weight-loss drugs that may help prevent heart attack and stroke.

Early phase trials in T2DM indicate that tirzepatide improves ...

The Trump administration is considering a shift in health care coverage, allowing Medicare and Medicaid to cover GLP-1 weight loss drugs.

Learn about FDA warnings, potential mechanisms linking tirzepatide to mood changes, and when to contact your healthcare provider about emotional side effects during weight loss treatment.

Not everyone responds equally to GLP-1 medications like Ozempic